“DualKnife J allows us to further innovative ESD procedures as part of an overall value-based care initiative, providing more minimally invasive procedures to patients so they may reap the benefits that come with avoiding more invasive forms of surgery,” Sergey V. Kantsevoy, director of therapeutic endoscopy at Mercy Medical Center, said in a press release. “We have come to rely on the DualKnife J as it can decrease procedural time and increase our efficiencies, and can also lead to better patient outcomes.”
The DualKnife J is a follow up to the company’s DualKnife. It offers two step knife length adjustments for optimal handling with a reduced risk of perforation. It can extend to 2mm or retract to 0.1mm while enabling dissection and lifting of the mucosa by injected saline solution into the submucosal layer. The dissection and lifting of the mucosa eliminates the need to change devices and shortens procedure times.
“Olympus stays true to its commitment to improve already excellent and best-in-class products, in this case by integrating the injection capability that will save physicians time and help get patients more quickly into recovery,” said Kurt Heine, group VP of the endoscopy division at Olympus America. “We expect DualKnife J to be a driver in bringing more practices into the value-based paradigm of minimally invasive procedures, which help reduce costs while improving patient outcomes and satisfaction.”